UnitedHealth (UNH) AI Stock Analysis

UnitedHealth

(BMV:UNH)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong cash generationUnitedHealth’s substantial operating and free cash flow supports investment across insurance, pharmacy, care delivery, and technology services while funding dividends and other capital needs. Free cash flow has also generally tracked earnings well, indicating meaningful underlying cash conversion despite recent growth volatility.

Negative Factors

Revenue and margin compressionThe recent deterioration in revenue and profitability indicates that UnitedHealth’s earnings base is under pressure despite its considerable scale. If weaker trends persist, lower margins could restrict reinvestment capacity, reduce operating flexibility, and make the long-term growth target harder to achieve.

UnitedHealth (UNH) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 365.29B
Dividend Yield: 2.03%
Average Volume (3M): 1,407
Price to Earnings (P/E): 23.2
Beta (1Y): -0.52
Revenue Growth: -7.27%
EPS Growth: ―
Country: Mexico
Employees: 390,000
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Healthcare Plans

UnitedHealth Business Overview & Revenue Model

Company Description

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthc...

UnitedHealth Earnings Call Summary

Earnings Call Date:Oct 12, 2026(Q3-2026)|% Change Since:10.89%|Next Earnings Date:Jan 19, 2027

Earnings Call SentimentPositive

The call was predominantly positive, with improved third-quarter earnings, a lower medical care ratio, raised 2026 adjusted EPS guidance, Medicare Advantage margin recovery, strong Optum operating metrics, AI and modernization progress, capital returns, and confidence in 2027 growth. The main challenges were persistently high medical costs, commercial trends above 11%, negative Medicaid core margins, No Surprises Act arbitration costs, and continued policy and funding pressures.

Positive Updates

Strong Third-Quarter Financial Performance

Third-quarter 2026 revenue was $113 billion, and adjusted earnings per share was $4.69, up from $2.92 a year ago. The consolidated medical care ratio improved to 88.4% from 89.9% last year.

Negative Updates

Persistently High Healthcare Costs

Costs remain stubbornly high across the healthcare landscape, particularly in specialty pharmacy and acute healthcare service intensity. Management also said care intensity remains elevated relative to historical norms and that clinician pricing pressure continues.

Company Guidance

UnitedHealth Group reaffirmed its 13%-16% long-term target growth range, views the lower end of its long-term 13%-16% growth rate as a more reasonable starting point for 2027, and updated 2026 adjusted EPS guidance to at least $20.50; it expects debt-to-cap ratio to approach 40% by year-end, dividends to exceed $8 billion by year-end, 2026 core Medicaid margins to be moderately better than negative 1%, and 2026 Medicare margins to be near the top end of the 2%-4% range. For 2027, more than 94% of Medicare-eligible individuals nationwide will have access to a UnitedHealthcare Medicare plan, approximately 90% will have access to a Medicare Advantage plan with a $0 premium option, chronic special needs plans will be available to nearly 50 million Medicare-eligible individuals, and the company expects to approach 75% of total members in four-plus Star plans compared to the industry average of 70%; Optum Health remains paced toward its 6%-8% target margin range by 2028, while Optum Insight expects meaningful progress in 2027, setting the foundation for accelerating growth in 2028 and beyond.

UnitedHealth Risk Analysis

UnitedHealth disclosed 21 risk factors in its most recent earnings report. UnitedHealth reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

UnitedHealth Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

MX:UNH against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CI	72Outperform	$78.80B	12.30	15.24%	2.08%	8.15%	31.47%
ELV	69Neutral	$90.76B	17.89	11.59%	1.64%	3.60%	-4.06%
CNC	64Neutral	$33.89B	23.13	6.78%	―	9.71%	―
HUM	60Neutral	$49.77B	38.92	6.91%	0.85%	18.33%	-18.53%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CVS	48Neutral	$115.43B	23.56	6.43%	2.95%	7.41%	6.51%

* Healthcare Sector Average

Performance Comparison

MX:UNH and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MX:UNH	Unitedhealth Group Inc.	7650.01	1674.73	28.03%
CNC	Centene	68.45	33.95	98.41%
CI	Cigna	298.23	45.34	17.93%
CVS	CVS Health Corp	90.25	14.15	18.59%
HUM	Humana	414.50	138.19	50.01%
ELV	Elevance Health, Inc.	420.07	112.99	36.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

UnitedHealth AI Stock Analysis